Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
3.200
+0.090 (2.89%)
At close: Jun 12, 2024, 4:00 PM
3.060
-0.140 (-4.38%)
After-hours: Jun 12, 2024, 5:45 PM EDT

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $473.54K in the twelve months ending March 31, 2024, with 283.80% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $148.00K with 124.24% year-over-year growth. In the year 2023, Ovid Therapeutics had annual revenue of $391.70K, a decrease of -73.93%.

Revenue (ttm)
$473.54K
Revenue Growth
+283.80%
P/S Ratio
479.42
Revenue / Employee
$11,838
Employees
40
Market Cap
227.02M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023391.70K-1.11M-73.93%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.57%
Dec 31, 202012.62M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Outset Medical 125.08M
The Joint 119.12M
Senseonics Holdings 23.30M
Profound Medical 5.33M
Opthea 385.28K
Atai Life Sciences 277.00K
Revenue Rankings